Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDSerina Therapeutics Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 2 | -$0.50 | -$0.44 | -$0.47 |
| Q2 2026 | 1 | -$0.48 | -$0.48 | -$0.48 |
| Q3 2026 | 1 | -$0.48 | -$0.48 | -$0.48 |
| Q4 2026 | 1 | -$0.40 | -$0.40 | -$0.40 |
Serina Therapeutics Inc. Earnings Date And Information
Serina Therapeutics Inc. last posted its earnings results on Thursday, November 13th, 2025. The company reported $-0.45 earnings per share for the quarter, topping analysts' consensus estimates of $-0.47 by $0.02. The company had revenue of 0 for the quarter and had revenue of 56.00 K for the year. Serina Therapeutics Inc. has generated $-2 earnings per share over the last year ($-1.51 diluted earnings per share) and currently has a price-to-earnings ratio of -1.18. Serina Therapeutics Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Serina Therapeutics Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2025 | Q3 2025 | -$0.47 | -$0.44 | 0.03 | $0 | $0 |
| 08/11/2025 | Q2 2025 | -$0.36 | -$0.64 | -0.28 | N/A | $130.00 K |
| 05/08/2025 | Q1 2025 | -$0.62 | -$0.49 | 0.13 | N/A | $0 |
| 03/24/2025 | Q4 2024 | $0.42 | -$0.31 | -0.73 | N/A | $-14,000 |
| 11/12/2024 | Q3 2024 | N/A | $0.16 | N/A | N/A | $14.00 K |
| 08/09/2024 | Q2 2024 | N/A | $0.61 | N/A | N/A | $0 |
| 05/14/2024 | Q1 2024 | N/A | -$3.38 | N/A | N/A | $5.00 K |
| 03/22/2024 | Q4 2023 | N/A | -$3.20 | N/A | N/A | $3.09 M |
| 11/14/2023 | Q3 2023 | N/A | $0.80 | N/A | N/A | $29.00 K |
| 06/29/2023 | Q2 2023 | N/A | -$2.47 | N/A | N/A | $0 |
| 03/29/2023 | Q1 2023 | N/A | -$3.04 | N/A | N/A | $30.00 K |
| 12/29/2022 | Q4 2022 | N/A | -$2.51 | N/A | N/A | $8.00 K |
| 09/28/2022 | Q3 2022 | N/A | -$2.26 | N/A | N/A | $9.00 K |
| 06/28/2022 | Q2 2022 | N/A | -$2.43 | N/A | N/A | $12.00 K |
| 03/29/2022 | Q1 2022 | N/A | -$2.51 | N/A | N/A | $5.00 K |
| 12/29/2021 | Q4 2021 | N/A | -$2.00 | N/A | N/A | $2.00 K |
| 09/28/2021 | Q3 2021 | N/A | -$1.81 | N/A | N/A | $24.00 K |
| 06/28/2021 | Q2 2021 | N/A | -$2.29 | N/A | N/A | $37.00 K |
| 03/30/2021 | Q1 2021 | N/A | -$1.95 | N/A | N/A | $56.00 K |
| 12/30/2020 | Q4 2020 | N/A | -$2.28 | N/A | N/A | $505.00 K |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Serina Therapeutics Inc. Earnings: FAQ's
In the previous quarter, Serina Therapeutics Inc. (:SER) reported $-0.45 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.47 by $0.02.
The conference call for Serina Therapeutics Inc.'s latest earnings report can be listened to online.
The conference call transcript for Serina Therapeutics Inc.'s latest earnings report can be read online.
Serina Therapeutics Inc. (:SER) has a recorded annual revenue of $56.00 K.
Serina Therapeutics Inc. (:SER) has a recorded net income of $-11,141,000.Serina Therapeutics Inc. has generated $-1.51 earnings per share over the last four quarters.
Serina Therapeutics Inc. (:SER) has a price-to-earnings ratio of -1.18 and price/earnings-to-growth ratio is 0.02.